Please provide your email address to receive an email when new articles are posted on . Moderate exacerbations shared similar characteristics with severe exacerbations. Lung function, limitations and ...
The AIRQ effectively identifies asthma exacerbation risk at 3 months and 12 months among patients with varying levels of asthma severity.
MedPage Today on MSN
New maintenance option approved for asthma
Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years ...
Tozorakimab met its primary endpoint in the MIRANDA trial, demonstrating the potential of IL-33 inhibition to reduce exacerbations and improve outcomes for a broad population of COPD patients. Topline ...
Underlying mood and sleep disorders may negatively affect asthma control, researchers find. “Asthma control, sleep quality, and mood are all critical factors in affecting an individual’s overall ...
Patients with acute COPD exacerbations are seen frequently in the emergency department (ED). Acute exacerbations are associated with significant morbidity, mortality and health care expenditures.
Please provide your email address to receive an email when new articles are posted on . DENVER — The use of several common antibiotics led to exacerbation of myasthenia gravis in a small cohort of ...
In the spring, patients with chronic obstructive pulmonary disease (COPD) may develop a common acute respiratory viral infection (ARVI) into a serious exacerbation. On April 20, Sergey Avdeev, MD, ...
March 18, 2010 — Pharmacotherapy, ventilation strategies, and other management issues regarding chronic obstructive pulmonary disease (COPD) exacerbations are reviewed in an article published in the ...
Compared with placebo, the time to first moderate or severe exacerbation was longer with mepolizumab. HealthDay News — For patients with chronic obstructive pulmonary disease (COPD) with a history of ...
A new asthma treatment, depemokimab, has shown promise in reducing exacerbations while maintaining a strong safety profile, according to findings presented at the 2025 American Academy of Allergy, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results